日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Natural History of Chronic Kidney Disease in Sickle Cell Disease

镰状细胞病慢性肾脏疾病的自然史

Ataga, Kenneth I

Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia

镰状细胞贫血症儿童和成人持续性蛋白尿多基因风险评分的开发

Zahr, Rima S; Kang, Guolian; Zhang, Xu; Rashkin, Sara R; Kovesdy, Csaba P; Takemoto, Clifford; Weiss, Mitch; Lebensburger, Jeffrey; Ataga, Kenneth I; Saraf, Santosh L

Enhanced PIEZO1 function contributes to the pathogenesis of sickle cell disease

PIEZO1功能增强与镰状细胞病的发生发展有关

Romero, Luis O; Bade, Manisha; Elsherif, Laila; Williams, Jada D; Kong, Xiangmei; Adebiyi, Adebowale; Ataga, Kenneth I; Ma, Shang; Cordero-Morales, Julio F; Vásquez, Valeria

Enhanced PIEZO1 Function Contributes to the Pathogenesis of Sickle Cell Disease

PIEZO1功能增强与镰状细胞病的发病机制有关

Romero, Luis O; Bade, Manisha; Elsherif, Laila; Williams, Jada D; Kong, Xiangmei; Adebiyi, Adebowale; Ataga, Kenneth I; Ma, Shang; Cordero-Morales, Julio; Vásquez, Valeria

Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline

2016 年 CDC 指南发布后,镰状细胞病患者的阿片类药物处方和治疗结果

Kang, Hyeun Ah; Wang, Bofei; Barner, Jamie C; Ataga, Kenneth I; Mignacca, Robert C; Chang, Alicia; Zhang, Yahan

Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial

利奥西呱治疗伴有高血压或蛋白尿的镰状细胞病患者(STERIO-SCD):一项随机、双盲、安慰剂对照的1/2期试验

Gladwin, Mark T; Gordeuk, Victor R; Desai, Payal C; Minniti, Caterina; Novelli, Enrico M; Morris, Claudia R; Ataga, Kenneth I; De Castro, Laura; Curtis, Susanna A; El Rassi, Fuad; Ford, Hubert James; Harrington, Thomas; Klings, Elizabeth S; Lanzkron, Sophie; Liles, Darla; Little, Jane; Nero, Alecia; Smith, Wally; Taylor, James G 6th; Baptiste, Ayanna; Hagar, Ward; Kanter, Julie; Kinzie, Amy; Martin, Temeia; Rafique, Amina; Telen, Marilyn J; Lalama, Christina M; Kato, Gregory J; Abebe, Kaleab Z

Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia

可溶性尿激酶型纤溶酶原激活物受体与肾脏疾病及其在镰状细胞贫血中的进展相关

Zahr, Rima S; Rashkin, Sara R; Ruiz, Maria Armila; Elsherif, Laila; Ren, Guohui; Salas, Guadalupe; Ataga, Kenneth I; Gordeuk, Victor R; Lebensburger, Jeffrey; Zhang, Xu; Saraf, Santosh L

Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel

妊娠期镰状细胞病及其相关并发症的管理:国际德尔菲专家组的研究结果

Sharma, Deva; Kozanoğlu, Ilknur; Ataga, Kenneth I; Benachi, Alexandra; Büyükkurt, Selim; Lanzkron, Sophie; Ozdogu, Hakan; Pancham, Shivan; Pecker, Lydia H; Robinson, Susan E; Yilmaz Baran, Safak; Howard, Jo

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease

机器学习预测镰状细胞病住院患者的急性肾损伤

Zahr, Rima S; Mohammed, Akram; Naik, Surabhi; Faradji, Daniel; Ataga, Kenneth I; Lebensburger, Jeffrey; Davis, Robert L

Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease

在患有镰状细胞病的成人患者中,羟基脲剂量递增与固定低剂量羟基脲的比较

Ogu, Ugochi O; Mukhopadhyay, Ayesha; Patel, Kruti; Nelson, Marquita N; Strahan, KayLee S; Wu, Lin; Smeltzer, Matthew P; Ataga, Kenneth I